An overview of the latest advances in gastric cancer
17 Jul 2019
An overview of the latest advances in gastric cancer
Supportive care in cancer treatment
Treating HER2-mutant advanced biliary tract cancer with neratinib
CAPTEM vs FOLFIRI as second-line treatment for mCRC patients
TRIBE2: Latest data for patients with mCRC
Entrectinib in NTRK-fusion positive gastrointestinal cancers
Latest results from KEYNOTE-181: Pembrolizumab versus chemotherapy as a second-line therapy for advanced oesophageal cancer
Challenges in global cancer control
Implementing the Breast Health Global Initiative guidelines
Cancer care in low and middle income countries
Cancer care in Latin America
ASCO 2019 and vision for cancer control